Combination of TGR-1202, Ublituximab, and Bendamustine is safe and highly active in patients with advanced DLBCL and Follicular Lymphoma

Drug Category: Array
Conference Category: Array
Lead Author: Lunning M, et al.
Published Date: 15/06/2017
Download Link: /wp-content/uploads/2019/03/U2%20Benda%20ICML%20Final.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top